Trademark: 79302421
Word
DMBIO Y
Status
Registered
Status Code
700
Status Date
Tuesday, November 16, 2021
Serial Number
79302421
Registration Number
6557534
Registration Date
Tuesday, November 16, 2021
Mark Type
5000
Filing Date
Wednesday, December 16, 2020
Published for Opposition
Tuesday, August 31, 2021

Trademark Owner History
DM Bio Limited - Original Registrant

Classifications
5 Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in the treatment of gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, for the treatment of dermatitis, skin pigmentation diseases, and in acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, and in allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer
42 Testing, inspection, research or development of pharmaceuticals; providing information relating to testing, inspection, research or development of pharmaceuticals; conducting clinical trials for pharmaceuticals
The mark consists of the stylized wording "DMBiO Y" with the letter "D" in blue, "M" in red, and "BiO" in grey. The letter "Y" appears as a superscript with the left branch in blue, right branch in red, and the stem in grey.
The color(s) blue, red and grey is/are claimed as a feature of the mark.

Trademark Events
Jul 22, 2022
Teas Change Of Correspondence Received
Jul 22, 2022
Teas Change Of Domestic Representatives Address
Jul 22, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 22, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 30, 2022
Final Decision Transaction Processed By Ib
May 6, 2022
Final Disposition Notice Sent To Ib
May 6, 2022
Final Disposition Processed
Feb 16, 2022
Final Disposition Notice Created, To Be Sent To Ib
Nov 16, 2021
Registered-Principal Register
Aug 31, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 31, 2021
Published For Opposition
Aug 29, 2021
Notification Processed By Ib
Aug 11, 2021
Notification Of Possible Opposition Sent To Ib
Aug 11, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 11, 2021
Notification Of Notice Of Publication E-Mailed
Jul 28, 2021
Approved For Pub - Principal Register
Jul 11, 2021
Refusal Processed By Ib
Jul 9, 2021
Teas/Email Correspondence Entered
Jul 8, 2021
Correspondence Received In Law Office
Jul 8, 2021
Teas Response To Office Action Received
Jun 15, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Jun 15, 2021
Refusal Processed By Mpu
Jun 11, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Jun 10, 2021
Non-Final Action Written
Jun 10, 2021
Assigned To Examiner
Jan 26, 2021
Application Filing Receipt Mailed
Jan 22, 2021
New Application Office Supplied Data Entered In Tram
Jan 22, 2021
Limitation From Original Application Entered
Jan 14, 2021
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24